
Expertise in value evidence outcomes, providing evidence to define, demonstrate and communicate value to inform healthcare decisions and optimise market access success.
Expertise in value evidence outcomes, providing evidence to define, demonstrate and communicate value to inform healthcare decisions and optimise market access success.
Leaders in qualitative and quantitative research techniques to support selection, development, evaluation and implementation of PRO, ObsRO, ClinRO and PerfO instruments for label claims and market access strategies.
A global team of experts combining strategic thinking with scientific rigour and commercial acumen to help you overcome the challenges of developing and commercialising healthcare products and services.
Working with pharmaceutical, medical device and healthcare service companies, our purpose is to improve patients’ lives by informing healthcare decisions through outcomes research, health economics and market access.
“Very much appreciated the continuous focus on quality of the contents. I’ve worked with many consultancy firms that produce large batches of ‘pretty slides’ full of buzz words. I often find myself searching for little nuggets of valuable information that are often difficult to find. My experience with Adelphi has been very different and satisfying. I appreciate the common sense approach, expertise and experience of the team.”
Senior Global Market Access, Pricing and Reimbursement Manager, large Pharma company
“Working in Adelphi Values is stimulating, challenging, fast-paced, exciting, worthwhile and fun – mostly all at the same time!”
Director, PROVE
Come join our team
Vacancy based inUSA
Vacancy based inUSA
Vacancy based inEurope
The ongoing COVID-19 pandemic continues to lead to extended lockdown measures in many countries around the world. There is uncertainty regarding the factors that are most effective at slowing the progression of this outbreak – does contact tracing, daily testing, isolation or a combination of these measures work best? A… Read More